Education
About Us
Working with TipRanks
Follow Us
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 12.14M | $ 7.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 10.43M | $ 7.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -104.57M | $ -139.71M | $ -132.28M | $ -123.54M | $ -113.73M |
| EBITDA | $ -102.86M | $ -137.94M | $ -131.11M | $ -122.22M | $ -112.82M |
| Net Income | $ -99.50M | $ -127.17M | $ -121.83M | $ -115.44M | $ -111.69M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 103.21M | $ 133.61M | $ 232.94M | $ 201.73M | $ 291.23M |
| Total Assets | $ 141.31M | $ 175.51M | $ 277.67M | $ 220.50M | $ 305.10M |
| Total Debt | $ 17.79M | $ 18.02M | $ 16.89M | $ 1.83M | $ 1.74M |
| Net Debt | $ -17.47M | $ 5.55M | $ -8.40M | $ -28.77M | $ -30.09M |
| Total Liabilities | $ 72.68M | $ 44.06M | $ 40.58M | $ 25.06M | $ 19.20M |
| Stockholders' Equity | $ 68.64M | $ 131.46M | $ 237.09M | $ 195.44M | $ 285.90M |
| Cash Flow | |||||
| Free Cash Flow | $ -56.37M | $ -103.65M | $ -110.58M | $ -86.75M | $ -85.85M |
| Operating Cash Flow | $ -56.30M | $ -102.89M | $ -107.06M | $ -83.73M | $ -83.53M |
| Investing Cash Flow | $ 53.46M | $ 90.19M | $ -34.65M | $ 81.69M | $ -263.80M |
| Financing Cash Flow | $ 24.82M | $ -120.00K | $ 136.40M | $ 815.00K | $ 164.90M |